![]() NETSPOT is currently available at Northside Hospital imaging centers in Atlanta, Cumming, Decatur, Fayetteville and Lawrenceville. €œPatients who are diagnosed with NETs early have a better chance of beating or managing the disease,†said Dr. “This provides a unique target for neuroendocrine tumor imaging.â€Ĭombined with PET/CT imaging, which offers higher resolution, three-dimensional and more rapid imaging than other imaging technologies, NETSPOT gives doctors a better picture of the disease and what they have to treat. €œSomatostatin is a hormone that regulates the endocrine system and is expressed by neuroendocrine cells,†said Dr. NETSPOT, after radiolabeling with Ga 68, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adults and pediatric patients. When injected into the patient, the agent binds to the receptors. Ga-68 dotatate is a radioactive diagnostic agent that is specifically designed to detect somatostatin receptors, including those in NETs. Lavely, nuclear medicine specialist at Northside Radiology Associates. The results will be presented in table form - if you wish to map the centers - select Map these contacts above the Name column.€œNETSPOT provides a more sensitive and specific imaging tool to determine location of disease, for staging and restaging of patients with well-differentiated and moderately-differentiated NETs,†said Dr. Netspot is a new radiotracer agent that uses gallium-68 dotatate instead of glucose. Once you have done this, click on the select button at the bottom of the page. Treatment The Roswell Park Advantage NetSpot Scan (Gallium-68 dotatate) Typical positron emission tomography (PET) scans have limitations in detecting neuroendocrine tumors because the slow-growing cells do not consume glucose rapidly. You may enter search information or leave it blank. You will be presented with a search tool. To use the tool - please click here or on the MAP image. Please note the reader training requires registration at the SNMMI website. To learn about how to read a NETSPOT image, click here for SNMMI NETSPOT reader training. To learn more about Ga68 and Theranostics, please visit our video channel from the 3rd Theranostics World Congress. ![]() If you like this service, please consider donating to NorCal CarciNET so we can continue to provide and maintain our services. This tool is offered as a public service - to inform us of inaccuracies, new locations or provide us contact information for a location - please This email address is being protected from spambots. PLEASE confirm coverage with insurer prior to the scan. Medicare does provide coverage for NETSPOT but not all private insurance does. Please work with your physician to determine if this diagnostic test is correct for you.Īs of Jthe FDA approved Ga68 DotaTate Scan (NETSPOT (tm)) for Neuroendocrine Tumors.īefore you go for your scan confirm how the scan will be paid for. ![]() This tool is not a recommendation for treatment or diagnostic test. ![]() The MAP image is not a current image as data is updated weekly. For the most up to date trial information please see. We have included some trial locations as well. This search tool/map is to help patients and physicians identify which centers are currently offering Ga68 PET/CT, PET/MRI and PRRT for either Neuroendocrine Tumors or Prostate Cancer. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |